Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study

Clin Gastroenterol Hepatol. 2023 Sep;21(10):2689-2691.e1. doi: 10.1016/j.cgh.2022.08.042. Epub 2022 Sep 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Budd-Chiari Syndrome* / epidemiology
  • Carcinoma, Hepatocellular* / epidemiology
  • Humans
  • Liver Neoplasms* / epidemiology
  • Risk